High thrombotic risk in cancer patients receiving immunotherapy – Medical University of Vienna Original study: Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy – Blood  

The post Cohort study: High thrombotic risk in cancer patients receiving immunotherapy appeared first on Links Medicus.